Quantitative determination of prostacyclin in biological fluids has been achieved by relatively non-specific bioassay techniques. The most widely used is that which utilizes its ability to inhibit platelet aggregation (Moncada et al., 1977) . More accurate physicochernical methods of analysis such as radioimmunoassay and g.1.c.-mass spectrometry (Claeys et al.. 1980; Morris et al., 1981) have relied on quantitative determination of the hydrolysis product of prostacyclin, 6-0x0-prostaglandin F,,.
We have modified a radioimmunoassay for 6-oxoprostaglandin F,, so that specific determination of prostacyclin can be performed. The specificity of the method relies on the ability of base and albumin to stabilize any prostacyclin present in a sample. Quantitative determination by radioimmunoassay of the 6-oxoprostaglandin F present in this sample, together with that in a duplicate that has undergone mild acid hydrolysis allows the original prostacyclin content to be calculated.
or diluted biological sample in IOOpl of 50m~-Tris/HCI buffer, pH 8.5 (Tris buffer), was cooled on ice in polystyrene tubes. 6-0x01 'H ]prostaglandin F,, (5nCi) was added in Tris buffer (IOOpI) containing 3% (w/v) human serum albumin (essentially fatty acid-free). This concentration was chosen to minimize any effect of endogenous albumin present in the samples. Antiserum (1 : 4500 dilution) to 6-oxoprostaglandin Flu (Hensby et al., 1981) in 10Opl of Tris buffer was then added. The contents of the tubes were vortex-mixed and incubated on ice for 3h. Then 2.5mg of bovine y-globulin in Tris buffer (1OOpl) was added, followed by saturated aqueous (NH,),SO, solution (400pl). The precipitate was sedimented by centrifugation (1OOOg for 15min at 4OC), the supernatant was decanted and the pellet was washed once with 800p1 of saturated aqueous (NH,)2S0, solution/water (1 : 1, v/v). The washed pellet was dissolved in distilled water (1.3ml), and the bound radioactivity was counted in Instagel (10ml) in a Packard 2650 scintillation counter.
Rat aortic rings were prepared by a modification of the method described by Moncada et al. (1977) . and incubated in citrated platelet-poor plasma. At given times 1OOpl of plasma was removed, and the prostacyclin was stabilized by the immediate addition of 2.5~1 of 2M-NaOH and stored at -2OOC overnight. The prostacyclin content of these plasma samples was assayed against standard prostacyclin on ADP-induced platelet aggregation and against standard 6-oxoprostaglandin F,, by radioimmunoassay by the procedure described below.
Prostacyclin. 6-oxoprostaglandin F
A portion of the sample (30pI) was diluted 20-or 100-fold wtih Tris buffer on ice. A 250pl portion was hydrolysed (addition of 5pl of 2~-H C I ) : after 15min at room temperature the pH was adjusted to 8.5 (addition of 5pl of ~M -N~O H ) . and the mixture was returned to ice. A second 250pl portion treated with 1 M-NaCl (10~1) provided the non-hydrolysed sample. Duplicates (2 x IOOpI) of these hydrolysed and non-hydrolysed samples were then analysed by radioimmunoassay for 6-oxoprostaglandin Fla. The prostacyclin concentration was calculated as the difference in 6-oxoprostaglandin F l u content between the hydrolysed and non-hydrolysed samples.
Under the conditions of the assay 10% displacement of 6-oxo13Hlprostaglandin F l u occurred with 15 pg of 6-0x0-prostaglandin FI,; this was taken to be the limit of sensitivity. Inter-assay variation (I0 x 200pg) and intra-assay variation (10 x 200pg) were 14% and 7% respectively. The crossreactivity of prostacyclin in the assay was determined from separate incubations of hydrolysed and non-hydrolysed prostacyclin samples. At 50% displacement of 6-oxoI3H Iprostaglandin F l u 7.9% cross-reaction was observed. This was considered to be acceptable, and probably represented the contamination of the prostacyclin with 6-oxoprostaglandin F,, and the adventitious hydrolysis of prostacyclin during the assay.
The analysis by bioassay of the prostacyclin concentration of plasma samples incubated with aortic rings (Ritter et at.. 1982) was correlated with that obtained by the radioimmunoassay described above. A correlation coefficient of 0.92 was obtained. It has been proposed that a factor that stimulates prostacyclin production is elevated in plasma from uraemic patients (Remuzzi et al., 1980) . We have employed the assay described in the present communication to determine the effect of plasma from patients in renal failure on the synthesis of prostacyclin by rat aortic rings. Aortic rings incubated with plasma from patients in renal failure for 30min produced 0.69 f0.15ng of prostacyclin/mg wet wt. of tissue (n = 8). Rings incubated for 30min in plasma from age-and sex-matched controls with normal renal function produced 1.16 0.35 ng of prostacyclin/ mg wet wt. of tissue (n = 8). There was no significant difference between the two groups.
